Tim Shannon has joined Canaan Partners as a venture partner, with a focus on the healthcare sector. He previously was president and CEO of CuraGen Corp., a publicly-held oncology drug company acquired by Celldex Therapeutics in October.
3 min read · 01 December 2009
Lumexis Corp., a Costa Mesa, Calif.-based developer of in-flight entertainment and connectivity systems, has raised $15 million in new VC funding. Perseus LLC led the round, which also includes an option for $7.5 million in additional investment. Return backers included PAR Capital Management and Zone Ventures.
3 min read · 01 December 2009
Soasta, a Mountain View, Calif.-based provider of cloud-based testing solutions, has raised $10 million in Series C funding. UV Partners led the round, and was joined by return backers Formative Ventures and The Entrepreneurs' Fund. The company previously raised around $10.4 million.
3 min read · 01 December 2009
1 min read · 01 December 2009
David Wurzer has joined Connecticut Innovations as a managing director. He previously was executive vice president, treasurer and CFO for CuraGen Corp. (Nasdaq: CRGN).
2 min read · 30 November 2009
Terapio Corp., an Austin, Texas-based developer of therapeutic applications based on a transport protein that helps move large molecules across the cell membrane, has raised $5 million in VC funding from Santé Ventures.
3 min read · 30 November 2009
Elara Pharmaceuticals GmbH, a Heidelberg, Germany-based developer of Hypoxia Inducible Factor (HIF) antagonizing drugs for treating cancer, has raised €2.6 million in Series A funding led by EMBL Ventures. The round also triggered an additional €2 million investment from the BMBF GOBio and the Biotechnologie Rhein-Neckar (BioRN) Spitzencluster programs.
3 min read · 30 November 2009
Heliatek GmbH, a Dresden, Germany-based developer of organic solar cells, has raised $27 million in second-round funding. Wellington Partners led the round, and was joined by Bosch, RWE Innogy Ventures, BASF Venture Capital, the High-Tech-Gründerfonds, eCAPITAL entrepreneurial Partners, the Technologiegründerfonds Sachsen Start-up GmbH & Co. KG and GP Bullhound Sidecar.
6 min read · 30 November 2009
EndoGastric Solutions Inc., a Redmond, Wash.-based medical device company focused on endoluminal reconstructive gastric procedures, has raised $21.5 million in Series E funding from company insiders. This includes the conversion of a $9.5 million bridge round peHUB reported on earlier this fall, based on a regulatory filing. EndoGastric Solutions previously raised around $82 million, from firms like Advanced Technology Ventures, Chicago Growth Partners, DeNovo Ventures, Foundation Medical Partners, MPM Capital and Oakwood Medical Investors.
2 min read · 30 November 2009
1 min read · 30 November 2009
